GoKawiilThank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Limit bets on clinical-trial outcomes being placed on prediction markets
Why This Matters
A Nature piece argues for limiting bets on clinical-trial outcomes on prediction markets, a call that lands as these platforms move from politics and sports into science and medicine. The concern matters because wagering on trial results touches the integrity of research and the incentives of people with access to non-public data. Full article text wasn't available here beyond the headline, so the specific proposals aren't detailed.
Key Takeaways
- Nature calls for restricting prediction-market bets on clinical-trial outcomes.
- Signals prediction markets are expanding into medical and scientific events, not just politics and sports.
- Raises questions about research integrity, insider information, and how regulators should respond.
Get alerts for these topics